Physician profile
Lorelei Mccloskey
NPI 1336429026
$4,083.82
in general payments reported to CMS, 2019-2025
32 companies · $35.99 in 2025
The $35.99 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,479 · 2020: $174 · 2021: $1,556 · 2022: $238 · 2023: $495 · 2024: $106 · 2025: $35.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $1,200.00 | 2021 | |
| Crossroads Extremity Systems, LLC | $592.34 | 2019 | |
| Arthrosurface Incorporated | $540.56 | 2019-2020 | |
| Bioventus LLC | $191.57 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Acell, INC. | $164.27 | 2019 | |
| Horizon Therapeutics Plc | $154.03 | 2019-2023 | Krystexxa |
| Medshape, INC. | $145.92 | 2021 | |
| Paratek Pharmaceuticals, INC. | $142.87 | 2021-2025 | Nuzyra |
| Smith+Nephew, INC. | $128.73 | 2019-2023 | Regranex, Collagenase Santyl, Evos Mini |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $108.72 | 2022-2023 | Jublia |
| Zimmer Biomet Holdings, INC. | $81.03 | 2020-2023 | |
| Integra Lifesciences Corporation | $69.16 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Osteomed LLC | $68.61 | 2019 | |
| Organogenesis INC. | $63.22 | 2022-2024 | Puraply |
| Musculoskeletal Transplant Foundation INC. | $61.36 | 2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $44.08 | 2019-2023 | |
| Nalu Medical, INC. | $43.56 | 2022 | |
| Journey Medical Corporation | $37.12 | 2021-2023 | |
| Nevro Corp. | $31.00 | 2023 | Senza |
| Cardiovascular Systems INC. | $27.44 | 2020 | |
| Osiris Therapeutics INC. | $23.64 | 2019 | |
| Acera Surgical, INC. | $22.47 | 2022 | |
| Polynovo North America LLC | $21.44 | 2024 | Novosorb Btm |
| Dynasplint Systems INC. | $21.14 | 2019 | |
| Melinta Therapeutics, LLC | $16.00 | 2019 | |
| Hartmann USA, INC. | $15.30 | 2023 | Zetuvit Plus |
| Access Pro Medical, LLC | $13.18 | 2023 | Matriderm |
| Stryker Corporation | $11.92 | 2021 | |
| Assertio Therapeutics, INC. | $11.55 | 2020 | |
| Kerecis Limited | $11.43 | 2022 | |
| Anika Therapeutics, INC. | $10.89 | 2021 | |
| Paragon 28, INC. | $9.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorelei Mccloskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.